Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patientsAnnalisa Adamo, Stefano Ugel|OncoImmunology|2023Cited by 12